Emerging insights into ethnic-specific TP53 germline variants

por Fischer, Nicholas W, Ma, Yu-Heng Vivian, Gariépy, Jean
Publicado 2023

Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers

por Prodeus, Aaron, Abdul-Wahid, Aws, Fischer, Nicholas W., Huang, Eric H-B, Cydzik, Marzena, Gariépy, Jean
Publicado 2015

A Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In Vivo

por Prodeus, Aaron, Sparkes, Amanda, Fischer, Nicholas W., Cydzik, Marzena, Huang, Eric, Khatri, Ismat, Young, Ashley, Woo, Lindsay, Chow, Chung Wai, Gorczynski, Reginald, Gariépy, Jean
Publicado 2018

Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network

por Samuel, Nardin, Wilson, Gavin, Said, Badr Id, Pan, Anna, Deblois, Genevieve, Fischer, Nicholas W., Alexandrova, Roumiana, Casallo, Guillermo, Paton, Tara, Lupien, Mathieu, Gariepy, Jean, Merico, Daniele, Hudson, Thomas J., Malkin, David
Publicado 2016

TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy

por Graziano, Francesco, Fischer, Nicholas W., Bagaloni, Irene, Di Bartolomeo, Maria, Lonardi, Sara, Vincenzi, Bruno, Perrone, Giuseppe, Fornaro, Lorenzo, Ongaro, Elena, Aprile, Giuseppe, Bisonni, Renato, Prisciandaro, Michele, Malkin, David, Gariépy, Jean, Fassan, Matteo, Loupakis, Fotios, Sarti, Donatella, Del Prete, Michela, Catalano, Vincenzo, Alessandroni, Paolo, Magnani, Mauro, Ruzzo, Annamaria
Publicado 2020